Equity Details
Price & Market Data
Price: $0.348
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $478,110,432
Daily Volume: 0
Performance Metrics
1 Week: 7.18%
1 Month: 19.00%
3 Months: 43.93%
6 Months: 41.02%
1 Year: -15.04%
YTD: 16.11%
About CytoDyn Inc. (CYDY)
Comprehensive review of CytoDyn Inc. (CYDY). Trading at 0.348, the stock has seen a daily change of $0.00 / 0.00%. Its market capitalization is 478,110,432. All performance data is available for analysis.
Company Details
Employees: 13
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. It has a collaboration with Creatv Bio. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.